Cell therapy talks: tackling post-transplant complications
Cell therapy talks: tackling post-transplant complications
Cellular therapies are emerging as promising options to manage complications following transplantation, offering targeted approaches to improve patient outcomes. In this series of expert talks, leading clinicians and researchers review clinical data and share the latest developments shaping this evolving field.
Use of TCRαβ/CD19-depleted grafts from HLA-haploidentical donors for the treatment of non-malignant disorders: is it the new black?
Pietro Merli, MD, speaking at the Miltenyi Biotec Corporate Symposium at the 49th Annual Meeting of the EBMT 2023. His presentation “Use of TCRαβ/CD19-depleted grafts from HLA-haploidentical donors for the treatment of non-malignant disorders: is it the new black?” is one of the four talks presented for “Cell therapy: latest advances and future visions‘’.
Pietro Merli, MD @ 49th EBMT Annual Meeting 2023
Pietro Merli, MD
Department of Pediatric Hematology/Oncology, Bambino Gesù Children's Hospital, Rome, Italy
Pietro Merli, MD, received his medical degree and pediatric specialization in Pavia, Italy, and completed post-graduate training in pediatric hematology/oncology and bone marrow transplantation in Rome, Italy. He is currently consultant at the Department of Hematology/Oncology, Cell and Gene Therapy at Bambino Gesù Children's Hospital, Rome, Italy where he conducts translational research on both malignant and non-malignant pediatric diseases.
He is member of the national commission for evaluating phase I trials at Italian Higher Institute of Health. Dr. Merli’s major research interests include the development of new transplant strategies to prevent and treat graft failure, graft-versus-host disease, infectious complications and leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Safety and efficacy of high-dose of memory (CD45RA+ depleted) donor lymphocyte infusion in pediatric recipients after hematopoietic stem cell transplantation
Dr. Antonio Perez Martinez, MD, PhD, speaking at the Miltenyi Biotec Corporate Symposium at the 49th Annual Meeting of the EBMT 2023. His presentation “Safety and efficacy of high-dose of memory (CD45RA+ depleted) donor lymphocyte infusion in pediatric recipients after hematopoietic stem cell transplantation” is one of the four talks presented for “Cell therapy: latest advances and future visions ‘’.
Dr. Antonio Perez Martinez, MD, PhD @ 49th EBMT Annual Meeting 2023
Dr. Antonio Perez-Martinez, MD, PhD
Head of Pediatric Hemato-Oncology and Hematopoietic Transplant Service, La Paz University Hospital, Spain
Dr. Antonio Perez-Martinez, MD, PhD, is a medical specialist in pediatrics and Head of Pediatric Hematology and Oncology Service at the University Hospital La Paz, Madrid, Spain. He is also Pediatric Department Head at the Autonomous University of Madrid and Principle Investigator at the Foundation for Biomedical Research, Hospital La Paz, and has experience in over 20 active research projects as a principal investigator.
You have previously chosen International as your location.
What do you want to do?